Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | RXRB | P28702 | 1/20 | 0.46 |
| ▸ | RXRG | P48443 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2280556 | 0.90 | TSHR (0.57) | L3MBTL1MCL1TSHRSMN1; SMN2TP53 | |
| SCHEMBL22434873 | 0.89 | L3MBTL1 (0.59) | L3MBTL1MCL1TSHRLMNA | |
| SCHEMBL15048513 | 0.89 | L3MBTL1 (0.53) | L3MBTL1MCL1TSHRTP53ALOX15 | |
| SCHEMBL7375365 | 0.82 | MCL1 (0.46) | L3MBTL1MCL1SMN1; SMN2TP53ALOX15 | |
| SCHEMBL2777259 | 0.82 | L3MBTL1 (0.64) | L3MBTL1MCL1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL10591492 | 0.82 | MCL1 (0.46) | L3MBTL1MCL1SMN1; SMN2TP53ALOX15 | |
| SCHEMBL31302989 | 0.82 | L3MBTL1 (0.64) | L3MBTL1MCL1SMN1; SMN2LMNAMEN1 | |
| Hydrochloric Acid SCHEMBL2777750 | 0.80 | L3MBTL1 (0.62) | L3MBTL1MCL1SMN1; SMN2LMNAMEN1 | |
| SCHEMBL1806524 | 0.80 | L3MBTL1 (1.00) | L3MBTL1MCL1TSHRTP53MMP2 | |
| SCHEMBL22578056 | 0.80 | MCL1 (0.61) | L3MBTL1MCL1TSHRSMN1; SMN2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2053918-B1 | PROPYL PHENOXY ETHERS FOR USE AS DELIVERY AGENTS | EMISPHERE TECH INC (US) | 2014-07-23 | — | — | EP | disclosed |
| EP-2053918-B1 | PROPYL PHENOXY ETHERS FOR USE AS DELIVERY AGENTS | EMISPHERE TECH INC (US) | 2014-07-23 | — | — | EP | disclosed |
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EMISPHERE TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | US | disclosed |
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EMISPHERE TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | US | disclosed |
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EMISPHERE TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EPX, HPD, CYP2C8 | L3MBTL1 3481/4885MCL1 1978/4885TSHR 3844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.